[1] [5] These occur in a substantial proportion of users and are related to the drug's mechanism of slowing gastric emptying
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials
I love a good glow-up moment, but some days
OkudaMBandoNTeraoJSasakiSSugiyamaSKunitsuguIet al
Dual-Action Mechanism GLP-1 Receptor Activation Increases insulin secretion in response to glucose Slows gastric emptying, keeping patients full longer Reduces glucagon secretion, stabilizing blood sugar GIP Receptor Activation Enhances insulin sensitivity and beta-cell function Supports fat metabolism and energy balance Amplifies GLP-1 effects for superior metabolic results Together, these mechanisms promote sustained weight loss, stabilize blood sugar, and improve metabolic function What to Expect with GLP-1 & GIP Treatment Patients may experience reduced appetite and mild nausea as their body adjusts
As you get closer to achieving your goals and based on your bodys unique response, your dosage can be adjusted